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HLH: A rare association with LGL Leukemia
Dayan Ojeda-Damas MD, Ayesha Hamid MD, Kevin Wu MD, Michael Lapelusa MS-3, Nabeel Sarhill
MD, Henry Kwang MD
University of Texas Rio Grande Valley. Internal Medicine Residency at Valley Baptist Medical Center.
Harlingen, TX
Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal syndrome characterized by excessive
immune activation. It is diagnosed in patients of all ages and is classified as either primary from gene
mutations or secondary from various triggers. We present an interesting case of HLH in a patient with
large granular lymphocytic leukemia (LGL).
Presentation
A 53-year-old female with a questionable history of inflammatory osteoarthritis presented with fever and
a diffuse papular erythematous rash. Her initial vital signs and labs were significant for temperature of
102.7F, HR 116/min, WBC 14000/mcl, platelets 96000/mcl, ALT 198 U/L, AST 185 U/L, and total
bilirubin 1.8 mg/dl. Given initial concerns for flea-borne disease, antibiotics were initiated without
improvement. Infectious disease consult recommended broadening antibiotics, but patient continued to
deteriorate and was noted to have progressive pancytopenia and an elevated ferritin of 1610 ng/ml.
Given suspicion for a non-infectious process, hematologic workup was initiated. Peripheral smear showed
an expanded population of CD8+ T-cell large granular lymphocytes. Hematology was consulted and
confirmed diagnosis of LGL by flow cytometry. At this point, patient rapidly deteriorated and developed
hallucinations, confusion, and lethargy. Patient was noted to have developed acute hyponatremia with
sodium levels dropping by more than 10 over 1 day and urine studies and exam consistent with SIADH
secondary to hematologic illness. Legionella and rickettsial disease panel were negative. MRI Brain was
unremarkable, but lumbar puncture demonstrated an increased LGL population. Further workup revealed
low fibrinogen of 124 mg/dl, elevated triglycerides of 296 mg/dl, extremely elevated IL-2 receptor alpha
level (CD25) of 4667 U/ml (expected 223-710), and hepatosplenomegaly on abdominal CT. Bone
marrow biopsy was normal. As patient met six of eight diagnostic criteria for HLH, she was started on
treatment with dexamethasone along with hypertonic saline for acute SIADH with marked improvement
of her clinical status over the next 3 days. The patient was subsequently discharged with prednisone with
plans for outpatient hematology follow-up.
Discussion
HLH was historically described as a rare familial disorder of the young, but has increasingly been also
recognized as an aggressive and potentially fatal syndrome in adults. Its presentation necessitates prompt
hematologic evaluation and management. Limited literature has discussed the rare association of
secondary HLH with LGL (<1% of cases), with our case demonstrating rapid and drastic improvement
with treatment of this unusual combination. Given its life-threatening nature, it is important for clinicians
to consider HLH when dealing with a similar clinical scenario.

